Barclays
OFIX icon

Barclays’s Orthofix Medical OFIX Stock Holding History

Barclays’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$262K – 7233
2018
Q4 		$262K Buy
+5,000
New +$284K ﹤0.01% 4382
2014
Q2 		– Sell
-65,000
Closed -$1.95M – 7747
2014
Q1 		$1.95M Buy
+65,000
New +$1.5M ﹤0.01% 2577

Other funds holding OFIX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays's OFIX Position: Q3 2026 in Review

Barclays increased its Orthofix Medical (OFIX) stake by 29% in Q3 2026, buying an estimated $91.5K and bringing the position to 39,642 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Barclays first reported a position in OFIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.4M in Q2 2013. 63 funds tracked by Wall St. Rank hold OFIX as of Q3 2026.

  • Barclays held 39,642 shares of Orthofix Medical worth $373K as of Q3 2026.
  • Barclays bought 8,882 Orthofix Medical shares in Q3 2026, an estimated $91.5K.
  • Orthofix Medical made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3624 holding.
  • Barclays first reported a position in Orthofix Medical in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Orthofix Medical position peaked at $3.4M in Q2 2013.
  • 63 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.